- Home
- BARK vs GOSS Comparison
BARK vs GOSS Comparison
Compare BARK & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- GOSS
- Stock Information
- Founded
- BARK 2011
- GOSS 2015
- Country
- BARK United States
- GOSS United States
- Employees
- BARK N/A
- GOSS N/A
- Industry
- BARK Department/Specialty Retail Stores
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- BARK Consumer Discretionary
- GOSS Health Care
- Exchange
- BARK Nasdaq
- GOSS Nasdaq
- Market Cap
- BARK 244.9M
- GOSS 262.5M
- IPO Year
- BARK N/A
- GOSS 2019
- Fundamental
- Price
- BARK $0.92
- GOSS $1.38
- Analyst Decision
- BARK Strong Buy
- GOSS Strong Buy
- Analyst Count
- BARK 3
- GOSS 3
- Target Price
- BARK $2.50
- GOSS $7.33
- AVG Volume (30 Days)
- BARK 1.2M
- GOSS 2.5M
- Earning Date
- BARK 08-06-2025
- GOSS 08-11-2025
- Dividend Yield
- BARK N/A
- GOSS N/A
- EPS Growth
- BARK N/A
- GOSS N/A
- EPS
- BARK N/A
- GOSS N/A
- Revenue
- BARK $484,182,000.00
- GOSS $124,590,000.00
- Revenue This Year
- BARK N/A
- GOSS N/A
- Revenue Next Year
- BARK $9.47
- GOSS $91.14
- P/E Ratio
- BARK N/A
- GOSS N/A
- Revenue Growth
- BARK N/A
- GOSS N/A
- 52 Week Low
- BARK $0.77
- GOSS $0.66
- 52 Week High
- BARK $2.56
- GOSS $1.55
- Technical
- Relative Strength Index (RSI)
- BARK 46.85
- GOSS 61.04
- Support Level
- BARK $0.89
- GOSS $1.20
- Resistance Level
- BARK $0.98
- GOSS $1.39
- Average True Range (ATR)
- BARK 0.05
- GOSS 0.09
- MACD
- BARK 0.02
- GOSS 0.00
- Stochastic Oscillator
- BARK 73.78
- GOSS 82.91
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.